Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
CXHS1300287	注射用头孢哌酮钠他唑巴坦钠(6:1)	cefoperazone sodium;tazobactam sodium	Lyophilized	Chemical Drugs(1.5)	New Drug Application	2013-12-19	湘北威尔曼制药股份有限公司,中国药科大学,广州威尔曼新药研发有限公司		In Approval	2021-04-21	view
CXHS1300288	注射用头孢哌酮钠他唑巴坦钠(6:1)	cefoperazone sodium;tazobactam sodium	Lyophilized	Chemical Drugs(1.5)	New Drug Application	2013-12-19	湘北威尔曼制药股份有限公司,中国药科大学,广州威尔曼新药研发有限公司		In Approval	2021-04-21	view
CXHS1300289	注射用头孢哌酮钠他唑巴坦钠(6:1)	cefoperazone sodium;tazobactam sodium	Lyophilized	Chemical Drugs(1.5)	New Drug Application	2013-12-19	湘北威尔曼制药股份有限公司	Welman (Xiang Bei) Pharmaceuticals Ltd	Certificate Issued	2015-10-29	view
CXHS1300286	注射用头孢哌酮钠他唑巴坦钠(6:1)	cefoperazone sodium;tazobactam sodium	Lyophilized	Chemical Drugs(1.5)	New Drug Application	2013-12-19	湘北威尔曼制药股份有限公司	Welman (Xiang Bei) Pharmaceuticals Ltd	Certificate Issued	2021-02-26	view